Literature DB >> 34480625

Gd-EOB-DTPA-enhanced MRI radiomics to predict vessels encapsulating tumor clusters (VETC) and patient prognosis in hepatocellular carcinoma.

Yixing Yu1, Yanfen Fan1, Ximing Wang1, Mo Zhu1, Mengjie Hu1, Cen Shi1, Chunhong Hu2.   

Abstract

OBJECTIVES: The study was to develop a Gd-EOB-DTPA-enhanced MRI radiomics model for preoperative prediction of VETC and patient prognosis in hepatocellular cancer (HCC).
METHODS: The study included 182 (training cohort: 128; validation cohort: 54) HCC patients who underwent preoperative Gd-EOB-DTPA-enhanced MRI. Volumes of interest including intratumoral and peritumoral regions were manually delineated in the hepatobiliary phase images, from which 1316 radiomics features were extracted. The least absolute shrinkage and selection operator (LASSO) and multivariable logistic regression were used to select the useful features. Clinical, intratumoral, peritumoral, combined radiomics, and clinical radiomics models were established using machine learning algorithms. The Kaplan-Meier survival analysis was used to assess early recurrence and progression-free survival (PFS) in the VETC + and VETC- patients.
RESULTS: In the validation cohort, the area under the curves (AUCs) of radiomics models were higher than that of the clinical model using random forest (all p < 0.05). The peritumoral radiomics model (AUC = 0.972;95% confidence interval [CI]:0.887-0.998) had significantly higher AUC than intratumoral model (AUC = 0.919; 95% CI: 0.811-0.976) (p = 0.044). There were no significant differences in AUC between intratumoral or peritumoral radiomics model (PR) and combined radiomics model (p > 0.05). Early recurrence and PFS were significantly different between the PR-predicted VETC + and VETC- HCC patients (p < 0.05). PR-predicted VETC was independent predictor of early recurrence (hazard ratio [HR]: 2.08[1.31-3.28]; p = 0.002) and PFS (HR: 1.95[1.20-3.17]; p = 0.007).
CONCLUSIONS: The intratumoral or peritumoral radiomics model may be useful in predicting VETC and patient prognosis preoperatively. The peritumoral radiomics model may yield an incremental value over intratumoral model. KEY POINTS: • Radiomics models are useful for predicting vessels encapsulating tumor clusters (VETC) and patient prognosis preoperatively. • Peritumoral radiomics model may yield an incremental value over intratumoral model in prediction of VETC. • Peritumoral radiomics-model-predicted VETC was an independent predictor of early recurrence and progression-free survival.
© 2021. European Society of Radiology.

Entities:  

Keywords:  Gd-EOB-DTPA; Hepatocellular carcinoma; Magnetic resonance imaging; Prognosis; Radiomics

Mesh:

Substances:

Year:  2021        PMID: 34480625     DOI: 10.1007/s00330-021-08250-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  4 in total

1.  Hepatocellular carcinoma pathologic grade prediction using radiomics and machine learning models of gadoxetic acid-enhanced MRI: a two-center study.

Authors:  Yeo Eun Han; Yongwon Cho; Min Ju Kim; Beom Jin Park; Deuk Jae Sung; Na Yeon Han; Ki Choon Sim; Yang Shin Park; Bit Na Park
Journal:  Abdom Radiol (NY)       Date:  2022-09-21

2.  Development and Validation of a Novel Nomogram for Predicting Vessels that Encapsulate Tumor Cluster in Hepatocellular Carcinoma.

Authors:  Renguo Guan; Wenping Lin; Jingwen Zou; Jie Mei; Yuhua Wen; Lianghe Lu; Rongping Guo
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

3.  Application of a Convolutional Neural Network for Multitask Learning to Simultaneously Predict Microvascular Invasion and Vessels that Encapsulate Tumor Clusters in Hepatocellular Carcinoma.

Authors:  Tongjia Chu; Chen Zhao; Jian Zhang; Kehang Duan; Mingyang Li; Tianqi Zhang; Shengnan Lv; Huan Liu; Feng Wei
Journal:  Ann Surg Oncol       Date:  2022-06-26       Impact factor: 4.339

4.  Radiomics approach based on biphasic CT images well differentiate "early stage" of adrenal metastases from lipid-poor adenomas: A STARD compliant article.

Authors:  Lixiu Cao; Wengui Xu
Journal:  Medicine (Baltimore)       Date:  2022-09-23       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.